Duchenne and Becker muscular dystrophy
Conditions
Interventions
A wearable device will be attached to walkable pediatric or adult patients (10 patients) to measure 3-axis acceleration data, electrocardiographic data, and surface temperature data. Continuous measur
Sponsors
National Hospital Organization Matsumoto Medical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with Duchenne or Becker muscular dystrophy (with or without genetic diagnosis) 2) Patients who can walk (350 m or more after walking for 6 minutes) 3) Patients who do not develop heart failure and respiratory failure (including not wearing a ventilator) 4) Patients who can visit the research institution on a regular basis 5) Patients who have obtained consent for this study, or patients who have obtained the consent of a substitute if they do not have the ability to consent.
Exclusion criteria
Exclusion criteria: 1) Patients not diagnosed with Duchenne or Becker muscular dystrophy 2) If you cannot walk (less than 350m after walking for 6 minutes) 3) Patients with both heart failure and respiratory failure 4) Patients who have difficulty visiting the research institution on a regular basis 5) Patients who do not consent to this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| physical activity data | — |
Secondary
| Measure | Time frame |
|---|---|
| ECG data and autonomic nervous activity (heart rate variability HRV) data | — |
Countries
Japan
Contacts
Public ContactAkinori Nakamura
National Hospital Organization Matsumoto Medical Center Department of Clinical Research
Outcome results
None listed